Kendra S Carmon

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Pharmaceutics

British journal of cancer

Molecular cancer research : MCR

Science signaling

University of Texas Health Science Center at Houston

University of Texas Health Science Center at Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Health Science Center at Houston Sep 01 2015

United States

Assistant Professor :: Texas Therapeutics Institute and The Brown Foundation Institute of Molecular Medicine

Education History

University of Texas Health Science Center at Houston May 01 2004 - May 01 2008

United States

PHD :: Integrative Biology & Pharmacology

Clarkson University Aug 01 2002 - May 01 2004

United States

MSC :: Chemistry

Clarkson University Aug 01 1998 - May 01 2002

United States

BSC :: Chemical Engineering

Publications

Jianghua Tu, Yukimatsu Toh, Adela M Aldana, Jake J Wen, Ling Wu, Joan Jacob, Li Li, Sheng Pan, Kendra S Carmon, Qingyun J Liu
Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma. Pharmaceutics 16 (7) (2024)
Jianghua Tu, Yukimatsu Toh, Adela M Aldana, Jake J Wen, Ling Wu, Joan Jacob, Li Li, Sheng Pan, Kendra S Carmon, Qingyun J Liu
Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma. Pharmaceutics 16 (7) (2024)
Jianghua Tu, Yukimatsu Toh, Adela M Aldana, Jake J Wen, Ling Wu, Joan Jacob, Li Li, Sheng Pan, Kendra S Carmon, Qingyun J Liu
Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma. Pharmaceutics 16 (7) (2024)
Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S Carmon
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 16 (7) (2024)
Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S Carmon
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 16 (7) (2024)
Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S Carmon
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 16 (7) (2024)
Joan Jacob, Liezl E Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J Liu, Julie H Rowe, Kendra S Carmon
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer. British journal of cancer (2023)
Tressie A Posey, Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E Francisco, Zhengdong Liang, Kendra S Carmon
Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells. Molecular cancer therapeutics (2023)
Joan Jacob, Liezl E Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J Liu, Julie H Rowe, Kendra S Carmon
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer. British journal of cancer (2023)
Joan Jacob, Liezl E Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J Liu, Julie H Rowe, Kendra S Carmon
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer. British journal of cancer (2023)
Joan Jacob, Liezl E Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J Liu, Julie H Rowe, Kendra S Carmon
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer. British journal of cancer (2023)
Jie Cui, Yukimatsu Toh, Soohyun Park, Wangsheng Yu, Jianghua Tu, Ling Wu, Li Li, Joan Jacob, Sheng Pan, Kendra S Carmon, Qingyun J Liu
Drug Conjugates of Antagonistic R-Spondin 4 Mutant for Simultaneous Targeting of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors 4/5/6 for Cancer Treatment. Journal of medicinal chemistry 64 (17) (2021)
Soohyun Park, Ling Wu, Jianghua Tu, Wangsheng Yu, Yukimatsu Toh, Kendra S Carmon, Qingyun J Liu
Unlike LGR4, LGR5 potentiates Wnt-β-catenin signaling without sequestering E3 ligases. Science signaling 13 (660) (2020)
Sheng Zhang, Treena Chatterjee, Carla Godoy, Ling Wu, Qingyun J Liu, Kendra S Carmon
GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism. Molecular cancer research : MCR 17 (11) (2019)
Ali Azhdarinia, Julie Voss, Sukhen C Ghosh, Jo A Simien, Servando Hernandez Vargas, Jie Cui, Wangsheng A Yu, Qingyun Liu, Kendra S Carmon
Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates. Molecular pharmaceutics 15 (6) (2018)

Kendra S Carmon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kendra S Carmon